Washington, D.C. 20549

Date of Report (Date of earliest event reported)
February 13, 2019
Annaly Capital Management, Inc.
(Exact Name of Registrant as Specified in its Charter)
(State or Other Jurisdiction
Of Incorporation)
File Number)
(I.R.S. Employer
Identification No.)
1211 Avenue of the Americas
New York, New York
(Address of Principal
Executive Offices)
(Zip Code)
Registrant’s telephone number, including area code: (212) 696-0100
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company  o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o


Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 13, 2019, the Board of Directors (the “Board”) of Annaly Capital Management, Inc. (the “Company”) elected Kathy Hopinkah Hannan, PhD, CPA as a member of the Board, effective immediately. Dr. Hannan has been appointed to the Board’s Audit Committee and Nominating/Corporate Governance Committee, and will stand for re-election to the Board at the Company’s 2019 Annual Meeting of Stockholders for a term of one year.
The Board determined that Dr. Hannan is an independent director within the meaning of the New York Stock Exchange listing standards and is an “audit committee financial expert” for purposes of the Securities and Exchange Commission (“SEC”) rules. There are no arrangements or understandings between Dr. Hannan and any other person pursuant to which she was elected.  There are also no family relationships between Dr. Hannan and any director or executive officer of the Company, and Dr. Hannan does not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
In connection with the election of Dr. Hannan, the Board increased its size from eleven to twelve directors. The Company will enter into its standard form of indemnification agreement with Dr. Hannan, a copy of which is filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on March 20, 2017. Dr. Hannan will also participate in the non-employee director compensation arrangements established by the Company for non-employee directors, as described under “Compensation of Directors” in the Company’s definitive proxy statement on Schedule 14A filed with the SEC on April 10, 2018.
Item 7.01
Regulation FD Disclosure.
On February 13, 2019, the Company issued a press release (the “Press Release”) announcing the increase in the size of the Board and election of Dr. Hannan as a member of the Board effective immediately. A copy of the Press Release is being furnished as Exhibit 99.1 hereto and is incorporated herein by reference.
The Press Release is being furnished pursuant to Item 7.01, and the information contained therein shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01    Financial Statements and Exhibits.
(d)        See Exhibit Index

99.1    Press Release, dated February 13, 2019, issued by Annaly Capital Management, Inc.

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Annaly Capital Management, Inc.
/s/ Glenn Votek
Glenn Votek
Chief Financial Officer
February 13, 2019